SCHEMBL30454948

SCHEMBL30454948

Nc1ncc(-c2ccc(NS(=O)(=O)CCN3CC[C@@H](O)C3)cc2)cc1OCc1c(F)ccc(F)c1Cl

nearest known ligand 0.52

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MET P08581 15/20 0.52
JAK2 O60674 1/20 0.42
MAP4K3 Q8IVH8 1/20 0.42
AXL P30530 3/20 0.39
MERTK Q12866 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL488219 1.00 MET (0.52) METJAK2MAP4K3AXLMERTK
SCHEMBL488277 0.95 MET (0.54) METJAK2MAP4K3
SCHEMBL30452637 0.95 MET (0.54) METJAK2MAP4K3
SCHEMBL488155 0.92 MET (0.47) METJAK2MAP4K3
SCHEMBL30453699 0.92 MET (0.47) METJAK2MAP4K3
SCHEMBL488126 0.88 MET (0.57) METJAK2MAP4K3
SCHEMBL30452597 0.88 MET (0.57) METJAK2MAP4K3
SCHEMBL488519 0.88 MET (0.56) METJAK2MAP4K3
SCHEMBL30453320 0.88 MET (0.56) METJAK2MAP4K3
SCHEMBL488348 0.87 MET (0.48) METJAK2MAP4K3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4599890-A2 SUNITINIB FOR PREVENTING AND/OR TREATING AMYOTROPHIC LATERAL SCLEROSIS Kyoto University (JP) 2025-08-13 EP disclosed
CN-113181362-B Medicament for preventing and/or treating amyotrophic lateral sclerosis 国立大学法人京都大学 2023-06-13 CN disclosed